Growth monitoring could screen children for celiac disease, enabling easier lab diagnosis
Roisin McGuigan |
Celiac disease (CD) has a prevalence of around 1–2 percent in Western populations, but less than a third of patients receive a diagnosis. Accurate blood-based tests are available, but the idea of population-based blood screening is controversial. Many symptoms of CD, such as poor weight gain and inconsistent growth are very nonspecific; which means it can be a challenge to identify which children might benefit from blood tests. Now, Finnish researchers are working to develop a noninvasive screening method to pinpoint CD earlier, and more accurately.
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.